Polymyxin B
| Effect of ECMO | Minimal impact on drug PK |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Therapeutic drug monitoring (if available) strongly recommended. Ref: Clin Pharmacokinet 2026;65:193. |
| Effect of ECMO | Minimal impact on drug PK |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Therapeutic drug monitoring (if available) strongly recommended. Ref: Clin Pharmacokinet 2026;65:193. |